UW-Madison researchers on the therapeutic potential of psychedelics, including MDMA. Madison was the only Midwest site for phase 3 trials of a psychedelic-assisted therapy treatment for Post-traumatic stress disorder. We learn about the potential for these substances in improving mental health.
Office of Strategic Communication